Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03RHZ
|
||||
| Former ID |
DIB001484
|
||||
| Drug Name |
MDL-27192
|
||||
| Synonyms |
3-(4-Chlorophenyl)-4-ethyl-1H-1,2,4-triazol-5(4H)-one; 5-(4-Chlorophenyl)-4-ethyl-3,4-dihydro-2H-1,2,4-triazol-3-one
|
||||
| Indication | Epileptic seizures [ICD9: 345.9, 780.3; ICD10:G40, P90, R56] | Phase 2 | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Target and Pathway | |||||
| Target(s) | NMDA receptor | Target Info | Modulator | [2], [3] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005914) | ||||
| REF 2 | Preclinical characterization of MDL 27,192 as a potential broad spectrum anticonvulsant agent with neuroprotective properties. Epilepsy Res. 1997 Apr;27(1):41-54. | ||||
| REF 3 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.